UCN-01 (UCN-01 as a therapeutic target)

UCN-01, also known as 7-hydroxystaurosporine, is a kinase inhibitor studied for its potential to treat cancer. It specifically targets certain enzymes called kinases that regulate cell division and survival. By blocking these kinases, UCN-01 can slow or stop the growth of cancer cells and make them more sensitive to other treatments like chemotherapy. Researchers explore UCN-01 as a therapeutic agent because it might improve outcomes in cancers that are resistant to conventional therapies. However, its development and use are still under investigation, and it is not yet an approved standard treatment.